Table 1.
Characteristics of human controls and AD patients, categorized as stages I to VI of Braak and Braak, used in this study
| Case number | Braak stage | Gender | Age | Age (mean ± s.d.m) | Postmortem delaya | |
|---|---|---|---|---|---|---|
| NFT | Aβ | |||||
| C1 | – | – | M | 78 | 6:00 | |
| C2 | – | – | M | 83 | 13:00 | |
| C3 | – | – | M | 73 | 79.2 ± 1.3 | 6:10 |
| C4 | – | ‐ | M | 76 | 11:30 | |
| C5 | I | – | M | 80 | 10:00 | |
| C6 | – | – | F | 86 | 4:00 | |
| C7 | – | – | M | 78 | 6:00 | |
| C8 | – | – | F | 69 | 12:00 | |
| C9 | – | – | M | 80 | 4:30 | |
| C10 | – | – | M | 79 | 4:45 | |
| C11 | – | – | F | 82 | 5:00 | |
| C12 | – | – | M | 80 | 5:30 | |
| C13 | – | – | M | 86 | 10:15 | |
| AD1 | II | – | M | 78 | 6:00 | |
| AD2 | II | – | M | 64 | 10:00 | |
| AD3 | II | – | F | 86 | 76.4 ± 3.6 | 13:30 |
| AD4 | II | A | F | 75 | 16:20 | |
| AD5 | II | – | F | 79 | 10:30 | |
| AD6 | III | A | M | 73 | 4:20 | |
| AD7 | III | – | M | 84 | 15:00 | |
| AD8 | III | – | M | 74 | 77.8 ± 3.2 | 9:00 |
| AD9 | III | B | M | 87 | 2:30 | |
| AD10 | III | B | M | 71 | 10:30 | |
| AD11 | IV | B | M | 82 | 2:30 | |
| AD12 | IV | B | M | 75 | 10:00 | |
| AD13 | IV | B | M | 70 | 79 ± 3.2 | 5:00 |
| AD14 | IV | B | M | 79 | 5:30 | |
| AD15 | IV | C | M | 89 | 7:00 | |
| AD16 | V | C | M | 76 | 5:00 | |
| AD17 | V | C | M | 79 | 4:15 | |
| AD18 | V | C | M | 79 | 76.4 ± 0.6 | 5:00 |
| AD19 | VI | C | F | 77 | 5:00 | |
| AD20 | VI | C | M | 77 | 5:00 | |
| AD21 | VI | C | F | 73 | 3:30 | |
| AD22 | VI | C | F | 74 | 3:30 | |
| AD23 | VI | C | F | 74 | 6:30 | |
| AD24 | VI | C | M | 78 | 7:00 | |
| AD25 | VI | C | F | 77 | 5:30 | |
a
*Time elapsed between death and sample extraction.